Northern Trust
ZYME icon

Northern Trust’s Zymeworks ZYME Stock Holding History

Northern Trust’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.02M Buy
320,210
+12,231
+4% +$289K ﹤0.01% 2197
2025
Q4 		$8.11M Sell
307,979
-40,274
-12% -$878K ﹤0.01% 2188
2025
Q3 		$5.95M Sell
348,253
-1,546
-0.4% -$22.1K ﹤0.01% 2398
2025
Q2 		$4.39M Sell
349,799
-37,124
-10% -$442K ﹤0.01% 2531
2025
Q1 		$4.61M Sell
386,923
-7,907
-2% -$108K ﹤0.01% 2462
2024
Q4 		$5.78M Buy
394,830
+23,903
+6% +$334K ﹤0.01% 2422
2024
Q3 		$4.66M Buy
370,927
+6,513
+2% +$70.9K ﹤0.01% 2517
2024
Q2 		$3.1M Sell
364,414
-53,834
-13% -$479K ﹤0.01% 2660
2024
Q1 		$4.4M Buy
418,248
+1,102
+0.3% +$12.2K ﹤0.01% 2549
2023
Q4 		$4.33M Sell
417,146
-2,721
-0.6% -$21.7K ﹤0.01% 2582
2023
Q3 		$2.66M Sell
419,867
-1,161
-0.3% -$8.57K ﹤0.01% 2781
2023
Q2 		$3.64M Buy
421,028
+390,949
+1,300% +$3.5M ﹤0.01% 2678
2023
Q1 		$272K Buy
30,079
+17,247
+134% +$150K ﹤0.01% 3716
2022
Q4 		$101K Sell
12,832
-1,403
-10% -$9.86K ﹤0.01% 4090
2022
Q3 		$88K Buy
14,235
+2,120
+17% +$12.8K ﹤0.01% 4152
2022
Q2 		$64K Sell
12,115
-33,685
-74% -$204K ﹤0.01% 4335
2022
Q1 		$300K Sell
45,800
-634
-1% -$5.65K ﹤0.01% 3947
2021
Q4 		$762K Sell
46,434
-50
-0.1% -$1.04K ﹤0.01% 3643
2021
Q3 		$1.35M Sell
46,484
-199,723
-81% -$6.64M ﹤0.01% 3444
2021
Q2 		$8.54M Buy
246,207
+205,639
+507% +$6.52M ﹤0.01% 2480
2021
Q1 		$1.28M Sell
40,568
-8,981
-18% -$365K ﹤0.01% 3483
2020
Q4 		$2.34M Sell
49,549
-2,544
-5% -$118K ﹤0.01% 3121
2020
Q3 		$2.43M Buy
52,093
+784
+2% +$26.9K ﹤0.01% 2966
2020
Q2 		$1.85M Buy
51,309
+41,391
+417% +$1.52M ﹤0.01% 3078
2020
Q1 		$352K Buy
9,918
+159
+2% +$6.51K ﹤0.01% 3537
2019
Q4 		$444K Buy
+9,759
New +$355K ﹤0.01% 3585

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust's ZYME Position: Q1 2026 in Review

Northern Trust increased its Zymeworks (ZYME) stake by 4% in Q1 2026, buying an estimated $289K and bringing the position to 320,210 shares worth $8.02M. The position accounts for ﹤0.01% of the portfolio, ranked #2197.

Northern Trust first reported a position in ZYME in Q4 2019 and has held it in 26 quarters since. The position peaked at $8.54M in Q2 2021. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Northern Trust held 320,210 shares of Zymeworks worth $8.02M as of Q1 2026.
  • Northern Trust bought 12,231 Zymeworks shares in Q1 2026, an estimated $289K.
  • Zymeworks made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #2197 holding.
  • Northern Trust first reported a position in Zymeworks in Q4 2019 and has held it in 26 quarters since.
  • Northern Trust's Zymeworks position peaked at $8.54M in Q2 2021.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.